About Enavate Sciences
Enavate Sciences is a company based in United States founded in 2022. Enavate Sciences has raised $300 million across 1 funding round from investors including Patient Square Capital. Enavate Sciences offers products and services including Investment Services. Enavate Sciences operates in a competitive market with competitors including Indegene, Zuellig Pharma, IntegriChain, Fishawack and Clinigen, among others.
- Headquarter United States
- SectorsHealthcare
- Email••••••••
- Website enavatesciences.com
- Social LinkedIn
- Total Equity Funding$300M (USD)
in 1 rounds
- Latest Funding Round$300M (USD), Series D
May 2022
- Investors
Products & Services of Enavate Sciences
Enavate Sciences offers a comprehensive portfolio of products and services, including Investment Services.
Provides funding and support to life sciences companies for growth.
Funding Insights of Enavate Sciences
Enavate Sciences has successfully raised a total of $300M through 1 strategic funding round. The most recent funding activity was a Series D round of $300 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $300M
- Total Rounds 1
- Last Round Series D — $300M
- First Round $300M
(May 2022)
- Investors Count 1
All 1 funding rounds of Enavate Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2022 | $300M | Series D | – | Patient Square Capital | – |
1 investors in total: 1 institutional.
Investors in Enavate Sciences
Enavate Sciences has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Patient Square Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Patient Square Capital is focused on health care investments. | – | patientsquarecapital.com | Menlo Park, United States |
Investor details for Enavate Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Enavate Sciences
10 people are tracked at Enavate Sciences (3 in leadership, 3 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
James Boylan | CEO | Leadership |
Edd Fleming | Executive Vice President, Commercialization | Leadership |
Del Corsano | Chief Financial Officer | Leadership |
Jim Momtazee | Chairman | Board & advisors |
Neel Varshney | Board Member | Board & advisors |
Laura Furmanski | Board Member | Board & advisors |
Amar Patel | Principal | Team |
Monika Juneja | Business Manager & Executive Assistant | Team |
Sara Nayeem | Evp, Investments | Team |
Christopher Lo | Associate | Team |
Complete people profiles for Enavate Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Enavate Sciences
2 dated milestones of Enavate Sciences, from founding to its latest funding, stage changes and deals.
- Founded Enavate Sciences is founded.
- Funding First funding round of $300.0M.
Competitors of Enavate Sciences
Enavate Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, Zuellig Pharma, IntegriChain, Fishawack and Clinigen, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| indegene.com | 1998 | Princeton, United States | $255.15M | 350 | Suite solutions are provided for payers and healthcare providers. | |
| zuelligpharma.com | 1992 | Singapore | – | – | Healthcare access in Asia is enhanced by Zuellig Pharma. | |
| integrichain.com | 2005 | Philadelphia, United States | $2M | 320 | Inventory, order and customer relationship management solution for life science suppliers. | |
| fishawack.com | 2001 | Brighton, United Kingdom | $23.59M | 45 | Fully integrated cross-border services are delivered to global pharmaceutical organizations. | |
| clinigengroup.com | 2010 | Burton-on-trent, United Kingdom | – | – | Specialty medicines are supplied via clinical trials and access programs. | |
| sciencegroup.com | 1995 | Cambridge, United Kingdom | – | 431 | Technology-based consultancy and product development services are provided. | |
| clearviewhcp.com | 2008 | Newton, United States | – | 381 | Strategic consulting services are provided to life sciences companies. | |
| fabtechnologies.com | 2002 | Mumbai, India | $175,048 | 279 | Instruments for biotech, pharmaceutical, and biomedical sectors are manufactured. |
Detailed competitors of Enavate Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Enavate Sciences
The website of Enavate Sciences (enavatesciences.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▼ 30.3% vs previous month
Latest news on Enavate Sciences
Complete news archive for Enavate Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Enavate Sciences
10 companies that operate in the same segment as Enavate Sciences (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Enavate Sciences
Enavate Sciences was founded in 2022.
Enavate Sciences is headquartered in United States.
James Boylan is the current CEO of Enavate Sciences.
Enavate Sciences is a funded company, having raised a total of $300M across 1 funding round to date. The company's 1st funding round was a Series D of $300M, raised on May 2022.
Enavate Sciences was founded in 2022 and is headquartered in the United States. Consulting services are delivered to pharmaceutical and biotechnology firms, focusing on enhancements to drug discovery and development processes. Market assessment services are also offered to evaluate commercial potential and strategic positioning. Operations center on advisory support for lifecycle management in the life sciences sector, with leadership provided by CEO James Boylan.
Enavate Sciences's top competitors include Indegene, Zuellig Pharma and IntegriChain.
Enavate Sciences offers Investment Services.
Enavate Sciences has 1 investor. Key investors include Patient Square Capital.